Cardiovascular and Metabolic Comorbidities in Patients with Plaque-Type Psoriasis Never Treated with Systemic Antipsoriatic Drugs: a Case-Control Study

1. Parisi R, Symmons D, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013;133(2):377-85.10.1038/jid.2012.339Search in Google Scholar

2. Nijsten T, Looman CW, Stern RS. Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol 2007;143(9):1113-21.10.1001/archderm.143.9.1113Search in Google Scholar

3. Ghoreschi K, Weigert C, Röcken M. Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol 2007;25:574-80.10.1016/j.clindermatol.2007.08.012Search in Google Scholar

4. Davidovici BB, Sattar N, Prinz J, Puig L, Emery P, Barker JN, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010;130(7):1785-96.10.1038/jid.2010.103Search in Google Scholar

5. Armstrong AW, Callis Duffin K, Garg A, Gelfand JM, Gottlieb AB, Krueger GG, et al. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists’ perspective: a report from the GRAPPA 2011: annual meeting. J Rheumatol 2012;39(11):2204-10.10.3899/jrheum.120825Search in Google Scholar

6. Feinstein AR. Th e pretherapeutic classification of comorbidity in chronic disease. J Chronic Dis 1970;23:455-568.10.1016/0021-9681(70)90054-8Search in Google Scholar

7. Klein DN, Riso LP. Psychiatric disorders: problems of boundaries and comorbidity. In: Costello CG, editor. Basic issues in psychopathology. New York: Guilford; 1993. p. 19-66.Search in Google Scholar

8. Pearce DJ, Morrison AE, Higgins KB, Crane MM, Balkrishnan R, Fleischer AB Jr, et al. Th e comorbid state of psoriasis patients in a university dermatology practice. J Dermatol Treat 2005;16(5-6):319-23.10.1080/0954663050033597716428152Search in Google Scholar

9. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296(14):1735-41.10.1001/jama.296.14.173517032986Search in Google Scholar

10. Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008;159(4):895-902.10.1111/j.1365-2133.2008.08707.x18616778Search in Google Scholar

11. Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mork C, et al. Self-reported stress reactivity and psoriasisrelated stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol 2004;18(1):27-36.10.1111/j.1468-3083.2004.00721.x14678528Search in Google Scholar

12. Bhole VM, Choi HK, Burns LC, Vera Kellet C, Lacaille DV, Gladman DD, et al. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) 2012;51(3):552-6.10.1093/rheumatology/ker349Search in Google Scholar

13. Cheng J, Kuai D, Zhang L, Yang X, Qiu B. Psoriasis increased the risk of diabetes: a meta-analysis. Arch Dermatol Res 2012;304(2):119-25.10.1007/s00403-011-1200-6Search in Google Scholar

14. Dreiher J, Weitzman D, Cohen AD. Psoriasis and osteoporosis: a sex-specifi c association? J Invest Dermatol 2009;129(7):1643-9.Search in Google Scholar

15. Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB. Th e risk of lymphoma in patients with psoriasis. J Invest Dermatol 2006;126(10):2194-201.10.1038/sj.jid.5700410Search in Google Scholar

16. Gottlieb AB, Chao C, Dann F. Psoriasis comorbidities. J Dermatol Treat. 2008;19(1):5-21.10.1080/09546630701364768Search in Google Scholar

17. Mussi A, Bonifati C, Carducci M, D`Agosto G, Pimpinelli D, D`Urso D, et al. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents 1997;11(3):115-8.Search in Google Scholar

18. Wakkee M, Th io HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profi les in untreated and treated psoriasis patients. Atherosclerosis 2007;190(1):1-9.10.1016/j.atherosclerosis.2006.07.011Search in Google Scholar

19. Naldi L, Griffiths CE. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefi ts and risks. Br J Dermatol 2005;52:597-615.10.1111/j.1365-2133.2005.06563.xSearch in Google Scholar

20. Gisondi P, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, et al. Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. J Eur Acad Dermatol Venereol 2013;27(1):e30-41.10.1111/j.1468-3083.2012.04450.xSearch in Google Scholar

21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.10.1016/0021-9681(87)90171-8Search in Google Scholar

22. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985;13:450-6.10.1016/S0190-9622(85)70188-0Search in Google Scholar

23. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3(1):55-78.10.1016/0049-0172(73)90035-8Search in Google Scholar

24. Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.10.1001/jama.285.19.248611368702Search in Google Scholar

25. Samarasekera E, Neilson JM, Warren RB, Parnham J, Smith CH. Incidence of cardiovascular disease in people with psoriasis: a systematic review and meta-analysis. J Invest Dermatol In press, doi: 10.1038/jid.2013.149.10.1038/jid.2013.14923528816Search in Google Scholar

26. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296(14):1735-41.10.1001/jama.296.14.173517032986Search in Google Scholar

27. Mallbris L, Akre O, Granath F, Yin L, Lindelof B, Ekbom A, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19(3):225-30.10.1023/B:EJEP.0000020447.59150.f9Search in Google Scholar

28. Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc 2013;2(2):PMID 23447749.10.1161/JAHA.113.000062364727823557749Search in Google Scholar

29. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988;91(3):197-201.10.1111/1523-1747.ep124648473411140Search in Google Scholar

30. Jensen P, Th yssen JP, Zachariae C, Hansen PR, Linneberg A, Skov L. Cardiovascular risk factors in subjects with psoriasis: a cross-sectional general population study. Int J Dermatol 2013;52(6):681-3.10.1111/j.1365-4632.2011.05408.x22512330Search in Google Scholar

31. Maradit-Kremers H, Dierkhising RA, Crowson CS, Icen M, Ernste FC, McEvoy MT. Risk and predictors of cardiovascular disease in psoriasis: a population-based study. Int J Dermatol 2013;52(1):32-40.10.1111/j.1365-4632.2011.05430.x353917023278607Search in Google Scholar

32. Brauchli YB, Jick SS, Curtin F, Meier CR. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. Br J Dermatol 2008;158(6):1299-307.10.1111/j.1365-2133.2008.08563.x18410416Search in Google Scholar

33. Wakkee M, van der Linden M, Nijsten T. Psoriasis appears not to be directly related with using cardiovascular and antidiabetic drugs. J Invest Dermatol 2008;128:2548.Search in Google Scholar

34. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and metaanalysis. JAMA Dermatol. 2013;149(1):84-91.10.1001/2013.jamadermatol.40623407990Search in Google Scholar

35. Cheng J, Kuai D, Zhang L, Yang X, Qiu B. Psoriasis increased the risk of diabetes: a meta-analysis. Arch Dermatol Res 2012;304(2):119-25.10.1007/s00403-011-1200-622210176Search in Google Scholar

36. Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, et al. Th e association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007;56(4):629-34.10.1016/j.jaad.2006.09.01717157411Search in Google Scholar

37. Brauchli YB, Jick SS, Meier CR. Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol 2008;159(6):1331-7.10.1111/j.1365-2133.2008.08814.x18782318Search in Google Scholar

38. Cohen AD, Dreiher J, Shapiro Y, Vidavsky L, Vardy DA, Davidovici B, et al. Psoriasis and diabetes: a populationbased cross-sectional study. J Eur Acad Dermatol Venereol 2008;22:585-9.10.1111/j.1468-3083.2008.02636.x18331320Search in Google Scholar

39. Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005;125:61-7.10.1111/j.0022-202X.2005.23681.x15982303Search in Google Scholar

40. Kim GW, Park HJ, Kim HS, Kim Sh, Ko HC, Kim BS, et al. Analysis of cardiovascular risk factors and metabolic syndrome in korean patients with psoriasis. Ann Dermatol 2012;24(1):11-510.5021/ad.2012.24.1.11328384322363149Search in Google Scholar

41. International Diabetes Federation [homepage on the Internet], [cited 2013 Jan 18]. Available from: http://www.idf.org.Search in Google Scholar

42. Gisondi P, Tessari G, Conti A, Piaserico S, Shianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007;157(1):68-73.10.1111/j.1365-2133.2007.07986.x17553036Search in Google Scholar

43. Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol 2010;76(6):662-5.10.4103/0378-6323.7246221079309Search in Google Scholar

44. Tekin NS, Tekin IO, Barut F, Sipahi EY. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients. Mediators Inflamm 2007;2007:ID 78454.10.1155/2007/78454180429717497039Search in Google Scholar

45. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006;298(7):321-8.10.1007/s00403-006-0703-z17021763Search in Google Scholar

46. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006;55(5):829-35.10.1016/j.jaad.2006.08.04017052489Search in Google Scholar

47. Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U. Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol 2008;159:1116-23.10.1111/j.1365-2133.2008.08786.x18717681Search in Google Scholar

48. Minov J, Karadžinska-Bislimovska J, Vasilevska K, Nelovska Z, Risteska-Kuc S, Stoleski S, et al. Smoking among Macedonian workers five years after the anti-smoking campaign. Arh Hig Rada Toksikol 2012;63(2):207-13. 10.2478/10004-1254-63-2012-215022728803Search in Google Scholar